A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors
NA
The purpose of this clinical trial is to evaluate the safety and efficacy o...
A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor
N/A
The aim of this retrospective study is to review and describe the safety an...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2017-02-28
Trial ID
NCT03049774
Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia
N/A
The purpose of this study is to determine whether Recombinant Human Interle...